An examination of the role of the two major basement membrane proteoglycans, agrin and perlecan, in oral cancer revealed that agrin and perlecan are highly expressed in oral SCC cells, and their knockdown suppressed cell migration and adhesion and increased resistance to cisplatin, making them potential therapeutic targets [29]. This evidence concerns the gene HSPG2 and lip and oral cavity carcinoma.